The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017

Overview of attention for article published in Lancet Infectious Diseases, September 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 4 news outlets
policy: 3 policy sources
twitter: 54 X users
facebook: 1 Facebook page

wikipedia: 2 Wikipedia pages
reddit: 5 Redditors
guideline: 1 clinical guideline source

Readers on

mendeley: 928 Mendeley

So far, Altmetric has seen 5 news stories from 4 outlets.

Genomic census of invasive nontyphoidal Salmonella infections reveals global and local human-to-human transmission – RawNews

Raw News Health, 09 Apr 2025

GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and…

Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant Foe

Contagion Live , 24 Sep 2022

Salmonella enterica subspecies enterica is a motile, Gram-negative bacteria divided into typhoidal serotypes (Salmonella Typhi…

Eli Lilly Japan and Daiichi Sankyo Enter a Collaborative Agreement to Commercialize Lasmiditan Succinate in Japan for the Acute Treatment of Migraines

FirstWord Pharma, 30 Aug 2021

Eli Lilly Japan K.K. (headquartered in Kobe-shi, Hyogo, Japan; Representative Director and President: Simone Thomsen…

Eli Lilly and Daiichi Sankyo Enter Commercialization Collaboration in Japan for Anti-CGRP Antibody Galcanezumab

FirstWord Pharma, 30 Oct 2020

Eli Lilly Japan K.K. (headquartered in Kobe-shi, Hyogo, Japan; Representative Director and President: Simone Thomsen…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 1 additional news stories.